Remede LLC – Trademark Portfolio

Entity Type: 16

Remede LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ROSELLE. The owner is based in Irvine, CA.

65 Palatine

Irvine, CA 92612

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

REMÈDE
REMÈDE
Pending 2025
REMEDE
REMEDE
Abandoned 2023
Trademark
Serial #86546294
Registered 2015
ROSELLE
ROSELLE
Registered 2014

Trademark Classifications

Remede LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

32
Light Beverages (4 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Remede LLC have?

Remede LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 abandoned.

What trademark classes does Remede LLC file in?

Remede LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 44 (Medical Services). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.

What are Remede LLC's most well-known trademarks?

Remede LLC's registered trademark portfolio includes well-known marks such as ROSELLE. These are among 2 currently registered trademarks in the portfolio.

What is Remede LLC's trademark registration success rate?

Remede LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.